Innovative Cellular Therapeutics Co.
Latest round
- Series C
Last raised
- Sep 2021
Total raised
- $68M
Investors
- 8
About Innovative Cellular Therapeutics Co.
, Ltd is a private clinical stage biotechnology company that is focused on the development of cellular immunotherapies for the treatment of solid tumors. It has a broad pipeline of chimeric antigen receptor T cell therapy(CAR-T)candidates targeting additional solid tumors.S. FDA IND. It developed cellular immunotherapies for the treatment of solid tumors, based on development of the technology of CoupleCAR platform. It has achieved promising preclinical and proof-of-concept clinical results in late-stage solid tumors, such as colorectal cancer and thyroid cancer. The company plans to develop technology of innovative CoupleCAR platform, accelerate the process of clinical trials in the United States and China, and promote the development of cell therapy products.
Who invested in Innovative Cellular Therapeutics Co.
8 investors across 5 rounds
See all investors in Innovative Cellular Therapeutics Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Innovative Cellular Therapeutics Co.
Who invested in Innovative Cellular Therapeutics Co.?
Innovative Cellular Therapeutics Co. has 8 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Innovative Cellular Therapeutics Co. raised?
Innovative Cellular Therapeutics Co. has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Innovative Cellular Therapeutics Co. last raise money?
Innovative Cellular Therapeutics Co.'s most recent round on record is a Series C, in Sep 2021.
What does Innovative Cellular Therapeutics Co. do?
, Ltd is a private clinical stage biotechnology company that is focused on the development of cellular immunotherapies for the treatment of solid tumors.
Where is Innovative Cellular Therapeutics Co. headquartered?
Innovative Cellular Therapeutics Co. is headquartered in Shanghai, China.
Which VCs invest in companies like Innovative Cellular Therapeutics Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Innovative Cellular Therapeutics Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Innovative Cellular Therapeutics Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.